Host response to intravenous injection of epsilon toxin in mouse model: A proteomic view

Proteomics

Volumn 13, Issue 1, 2013, Pages 89-107

  Kumar, Bhoj ^a   Alam, Syed Imteyaz ^a   Kumar, Om ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Clostridium perfringens; Differential proteomics; Epsilon toxin; Intoxication; Microbiology

Indexed keywords

ACTIN; ALBUMIN; APOLIPOPROTEIN A1; EPSILON TOXIN; FIBRINOGEN; GLUTATHIONE PEROXIDASE 3; PEROXIREDOXIN 5; PLASMINOGEN; TOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CALCIUM HOMEOSTASIS; CELL LYSATE; CELLULAR STRESS RESPONSE; CENTRAL NERVOUS SYSTEM; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; FEMALE; IMMUNE RESPONSE; MOUSE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEOMICS;

ANIMALS; BACTERIAL TOXINS; BIOLOGICAL MARKERS; BRAIN; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY DISEASES; MICE; PROTEINS; SHEEP;

CLOSTRIDIUM PERFRINGENS; OVIS ARIES;

EID: 84872410530     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200227     Document Type: Article

References (51)

1. Titball, R. W., Rood, J. I., in: Sussman, M. (Ed.), Molecular Medical Microbiology, Academic Press, United Kingdom 2002, pp. 1875-1903.
2. Popoff, M. R., Epsilon toxin: a fascinating pore-forming toxin. FEBS J. 2011, 278, 4602-4615.
3. Petit, L., Gibert, M., Popoff, M. R., Clostridium perfringens toxinotype and genotype. Trends Microbiol. 1999, 7, 104-110.
4. Knapp, O., Stiles, B. G., Popoff, M. R., The aerolysin-like toxin family of cytolytic, pore-forming toxins. Open Toxicol. J. 2010, 3, 53-68.
5. Hunter, S. E., Clarke, I. N., Kelly, D. C., Titball, R. W., Cloning and nucleotide sequencing of the Clostridium perfringens epsilon-toxin gene and its expression in Escherichia coli. Infect. Immun. 1992, 60, 102-110.
6. Brown, M. B., Savva, C. G., da Costa, S. P. F., Naylor, C. E. et al., Molecular basis of toxicity of Clostridium perfringens epsilon toxin. FEBS J. 2011, 23, 4589-4601.
7. Adamson, R. H., Ly, J. C., Ochi, S., Fernandez-Miyakawa, M. et al., Clostridium perfringens epsilon-toxin increases permeability of single perfused microvessels of rat mesentery. Infect. Immun. 2005, 73, 4879-4887.
8. Nagahama, M., Sakurai, J., High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain. Infect. Immun. 1992, 60, 1237-1240.
9. Finnie, J. W., Hajduk, P., An immunohistochemical study of plasma albumin extravasation in the brain of mice after the administration of Clostridium perfringens type D epsilon toxin. Aust. Vet. J. 1992, 69, 261-262.
10. Morgan, K. T., Kelly, B. G., Buxton, D., Vascular leakage produced in the brains of mice by Clostridium welchii type D toxin. J. Comp. Pathol. 1975, 85, 461-466.
11. Nagahama, M., Sakurai, J., Distribution of labeled Clostridium perfringens epsilon toxin in mice. Toxicon 1991, 29, 211-217.
12. Lonchamp, E., Dupont, J., Wioland, L., Courjaret, R. et al., Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release. PLoS One 2010, 5, e13046.
13. Miyamoto, O., Sumitami, K., Nakamura, T., Yamagami, S. et al., Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol. Lett. 2000, 189, 109-113.
14. Shortt, S. J., Titball, R. W., Lindsay, C. D., An assessment of the in vitro toxicology of Clostridium perfringens type D epsilon-toxin in human and animal cells. Hum. Exp. Toxicol. 2000, 19, 108-116.
15. Petit, L., Gibert, M., Gillet, D., Laurent-Winter, C. et al., Clostridium perfringens epsilontoxin acts on MDCK cells by forming a large membrane complex. J. Bacteriol. 1997, 179, 6480-6487.
16. Robertson, S. L., Li, J., Uzal, F. A., McClane, B. A., Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin. PLoS One 2011, 6, e22053.
17. Chassin, C., Bens, M., de Barry, J., Courjaret, R. et al., Pore-forming epsilon toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am. J. Physiol. Renal Physiol. 2007, 293, F927-F937.
18. Marmur, J., Procedure for the isolation of deoxyribonucleic acid from microorganisms. J. Mol. Biol. 1961, 3, 208-218.
19. Dixit, A., Alam, S. I., Dhaked, R. K., Singh, L., Development of an immunodetection test for a botulinum like neurotoxin produced by Clostridium sp. RKD. Ind. J. Med. Res. 2006, 124, 355-362.
20. 50 and its error by means of log-probit graph paper. Proc. Soc. Exp. Bio. Med. 1944, 57, 261.
21. Butt, R. H., Coorssen, J. R., Postfractionation for enhanced proteomic analyses: routine electrophoretic methods increase the resolution of standard 2D-PAGE. J. Proteome Res. 2005, 4, 982-991.
22. Sengupta, N., Alam, S. I., Kumar, B., Kumar, R. B. et al., Comparative proteomic analysis of extracellular proteins of Clostridium perfringens type A and type C strains. Infect. Immun. 2010, 78, 3957-3968.
23. Blackshear, P. J., Systems for polyacrylamide gel electrophoresis, in: Jaeoby, W. B. (Ed.), Methods in Enzymology, Volume 104, Academic Press, New York 1984, pp. 237-255.
24. Mao, S., Luo, Y., Zhang, T., Li, J. et al., Proteome reference map and comparative proteomic analysis between a wild type Clostridium acetobutylicum DSM 1731 and its mutant with enhanced butanol tolerance and butanol yield. J. Proteome Res. 2010, 9, 3046-3061.
25. Dhanwani, R., Khan, M., Alam, S. I., Rao, P. V. L. et al., Differential proteomic analysis of Chikungunya virus-infected new-born mice tissue reveal implication of stress, inflammatory and apoptotic pathways in disease pathogenesis. Proteomics 2011, 11, 1936-1951.
26. Crockett, D. K., Fillmore, G. C., Elenitoba-Johnson, K. S. J., Lim, M. S., Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico. Proteomics 2005, 5, 1250-1262.
27. Lee, J., Chan, S. L., Mattson, M. P., Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain. Neuromol. Med. 2002, 2, 29-45.
28. Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M. et al., The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011, 39, D561-D568.
29. Borkowski, J., Gmyrek, G. B., Madej, J. P., Nowacki, W. et al., Serum and peritoneal evaluation of vitamin D-binding protein in women with endometriosis. Postepy. Hig. Med. Dosw. 2008, 62, 103-109.
30. Malard, V., Gaillard, J. C., Bérenguer, F., Sage, N. et al., Urine proteomic profiling of uranium nephrotoxicity. Biochim. Biophys. Acta 2009, 1794, 882-891.
31. Satchell, K. J., Actin crosslinking toxins of Gram-negative bacteria. Toxins (Basel) 2009, 1, 123-133.
32. Muetzelburg, M. V., Hofmann, F., Just, I., Pich, A., Identification of biomarkers indicating cellular changes after treatment of neuronal cells with the C3 exoenzyme from Clostridium botulinum using the iTRAQ protocol and LC-MS/MS analysis. J. Chromatogr. B 2009, 877, 1344-1351.
33. Wheeler, D., Sneddon, W. B., Wang, B., Friedman, P. A. et al., NHERF-1 and the cytoskeleton regulate the traffic and membrane dynamics of G protein-coupled receptors. J. Biol. Chem. 2007, 282, 25076-25087.
34. Boll, W., Ehrlich, M., Collier, R. J., Kirchhausen, T., Effects of dynamin inactivation on pathways of anthrax toxin uptake. Eur. J. Cell Biol. 2004, 83, 281-288.
35. Zhang, P., Liu, B., Kang, S. W., Seo, M. S. et al., Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J. Biol. Chem. 1997, 272, 30615-30618.
36. Rutkowski, D. T., Kaufman, R. J., A trip to the ER: coping with stress. Trends Cell Biol. 2004, 14, 20-28.
37. Paton, A. W., Beddoe, T., Thorpe, C. M., Whisstock, J. C. et al., AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 2006, 443, 548-552.
38. Lee, S. Y., Lee, M. S., Cherla, R. P., Tesh, V. L., Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells. Cell. Microbiol. 2008, 10, 770-780.
39. Tamayo, A. G., Slater, L., Taylor-Parker, J., Bharti, A. et al., GRP78(BiP) facilitates the cytosolic delivery of anthrax lethal factor (LF) in vivo and functions as an unfoldase in vitro. Mol. Microbiol. 2011, 81, 1390-1401.
40. Choi, W. S., Lee, E., Lim, J., Oh, Y. J., Calbindin-D28K prevents drug-induced dopaminergic neuronal death by inhibiting caspase and calpain activity. Biochem. Biophys. Res. Commun. 2008, 371, 127-131.
41. Prathyuman, S., Sellappa, S., Joseph, S., Keyan, K. S., Enhanced calreticulin expression triggers apoptosis in the MCF-7 cell line. Asian Pac. J. Cancer Prev. 2010, 11, 1133-1136.
42. Combs, C. K., Karlo, J. C., Kao, S. C., Landreth, G. E., Beta-amyloid stimulation of microglia and monocytes results in TNF alpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 2001, 21, 1179-1188.
43. Butterfield, D. A., Lange, M. L., Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism. J. Neurochem. 2009, 111, 915-933.
44. Sapra, R., Gaucher, S. P., Lachmann, J. S., Buffleben, G. M. et al., Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin. Microb. Pathog. 2006, 41, 157-167.
45. Dirik, E., Yis, U., Paşaoǧlu, G., Chambaz, C. et al., Recurrent attacks of status epilepticus as predominant symptom in 3-methylcrotonyl-CoA carboxylase deficiency. Brain Dev. 2008, 30, 218-220.
46. Zou, J., Wang, Y. X., Dou, F. F., Lu, H. Z. et al., Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons. Neurochem. Int. 2010, 56, 577-584.
47. Papageorgiou, I. E., Gabriel, S., Fetani, A. F., Kann, O. et al., Redistribution of astrocytic glutamine synthetase in the hippocampus of chronic epileptic rats. Glia 2011, 59, 1706-1718.
48. Li, M. H., Kwok, F., An, X. M., Chang, W. R. et al., Crystallization and preliminary crystallographic studies of pyridoxal kinase from sheep brain. Acta Crystallogr. Sect. D: Biol. Crystallogr. 2002, 58, 1479-1481.
49. Nitsch, C., Okada, Y., Differential decrease of GABA in the substantia nigra and other discrete regions of the rabbit brain during the preictal period of methoxypyridoxine-induced seizures. Brain Res. 1976, 105, 173-178.
50. Kim, J. E., Kim, D. W., Kwak, S. E., Kwon, O. S. et al., Potential role of pyridoxal-5'-phosphate phosphatase / chronopin in epilepsy. Exp. Neurol. 2008, 211, 128-140.
51. Kaestner, U., Hallmen, C., Wiese, M., Leistner, E. et al., The human pyridoxal kinase, a plausible target for ginkgotoxin from Ginkgo biloba. FEBS J. 2007, 274, 1036-1045.